发明名称 PHARMACOLOGICALLY ACTIVE CNS COMPOUNDS
摘要 THE INVENTION PROVIDES A SERIES OF COMPOUNDS OF FORMULA (1)(FORMULA I)AND SALTS THEREOF, WHEREIN FOR EXAMPLE, R1 AND R2, WHICH MAY BE THE SAME OR DIFFERENT EACH REPRESENT -NR13R14 WHERE R13 AND R14 MAY EACH INDEPENDENTLY REPRESENT HYDROGEN OR ALKYL OR, TAKEN TOGETHER WITH THE NITROGEN ATOM TO WHICH THEY ARE ATTACHED FORM A HETEROCYCLIC RING, OPTIONALLY SUBSTITUTED BY ONE OR MORE ALKYL OR ARYLALKYL GROUPS AND OPTIONALLY CONTAINING A FURTHER HETEROATOM;R3 IS HYDROGEN, HALOALKYL, ALKOXYMETHYL OR ALKYL;R4 IS HYDROGEN, NITRO OR HALO;R5 IS HYDROGEN OR HALO;R6 IS HYDROGEN, HALO, NITRO, AMINO, ALKYLAMINO OR DIALKYLAMINO;R7 IS HYDROGEN OR HALO;R8 IS HYDROGEN OR HALO;THE COMPOUNDS MAY BE USED FOR THE TREATMENT OR PROPHYLAXIS OF A NEURODEGENERATIVE OR OTHER NEUROLOGICAL DISORDER OF THE CNS, THE AETIOLOGY OR WHICH INCLUDES EXCESSIVE RELEASE OF THE NEUROTRANSMITTER GLUTAMATE.
申请公布号 MY136248(A) 申请公布日期 2008.08.29
申请号 MYPI9501459 申请日期 1991.05.31
申请人 THE WELLCOME FOUNDATION LIMITED 发明人 MICHAEL JOHN LEACH;MALCOLM STUART NOBBS;RAMACHANDRAN IYER;PHILIP ALAN SKONE;CLIVE LEONARD YEATES
分类号 A61K31/505;A61K;A61K31/13;A61K31/445;A61K31/535;A61P9/10;A61P25/00;A61P25/28;C07D;C07D239/28;C07D239/42;C07D239/48;C07D401/04;C07D403/04;C07D413/04 主分类号 A61K31/505
代理机构 代理人
主权项
地址